Skip to main content
Home
  • en
  • fr
  • Profile
    • About DEINOVE
    • Board of Directors
    • Executive Committee
    • Founders
    • A word from the CEO
  • Antibiotics
    • About
    • Antimicrobial resistance
    • Portfolio
    • The AGIR program
    • Discovery platform
    • Partners
  • Bioactives
    • About
    • Biodiversity
    • Portfolio
    • Platform of Expertise
    • Partners
  • Investor room
    • Corporate governance
    • DEINOVE Shares
    • Financial Calendar
    • Documentation Center
    • Press releases
    • Investor relations
  • News & events
    • Press releases
    • Events
    • Press coverage
  • Careers
    • Join DEINOVE
    • Open positions
  1. Home
  2. News & events
  3. Press releases

Press releases

14.06.2016

DEINOVE completes the 2nd key milestone of its DEINOCHEM program and receives € 1.5 million from ADEME

ADEME has validated the 2nd key milestone of the DEINOCHEM program. Crossing this milestone was conditional on achieving deliverables...
24.05.2016

DEINOVE awarded at the Worldwide Innovation Challenge

The goal of this competition is to bring out the talents and future champions of the French economy through eight strategic goals set by...
09.05.2016

DEINOVE partners with TOULOUSE WHITE BIOTECHNOLOGY to optimize deinococcus production

DEINOVE and TWB undertake a collaborative project to optimize the metabolic fluxes of Deinococcus . This partnership aims to strengthen...
21.04.2016

DEINOVE selected to join the Tech 40 label

The Tech 40 label recognizes particularly outstanding listed technology companies. Deinove is one of the 40 companies selected from among...
24.03.2016

Annual results for the fiscal year 2015: Significant strengthening of the cash position and continuing progress on all programs

Cash position sharply improved by the December 2015 capital increase Reduction of net loss to €6.4m, vs. €6.5m in 2014 Growth in operating...
14.03.2016

DEINOVE and ARBIOM join forces to develop a “carbon-free” chemical industry

The two companies have started a collaboration to demonstrate the synergy of their respective technologies for the valorization of non-food...
01.03.2016

DEINOVE to present at upcoming U.S. investors conference

The ROTH conference brings together several thousand U.S. investors focused on small and mid-cap growth companies. Emmanuel PETIOT will...
18.02.2016

DEINOVE strengthens significantly its international intellectual property and confirms its value creation strategy

DEINOVE received from the US an agreement for issuance of its patent PF7: "Bacteria and uses thereof", which refers to the metabolic...
08.02.2016

DEINOVE confirms its carotenoids commercialization potential thanks to major progress

Increased number of target molecules with now five carotenoids produced at the lab scale paving the way for different markets Increased...
18.01.2016

DEINOVE announces its financial calendar for 2016

DEINOVE (Alternext Paris: ALDEI), a biotech company developing innovative processes for producing biofuels and bio-based chemicals from non...
  • « first
  • ‹ previous
  • …
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • next ›
  • last »

News & events

  • Press releases
  • Events
    • Past events
  • Press coverage
  • Contact
  • Location
  • Legal Info
  • Site map
  • Privacy Policy

Profile

  • About DEINOVE
  • Board of Directors
  • Executive Committee
  • Founders
  • A word from the CEO

Antibiotics

  • About
  • Antimicrobial resistance
  • Portfolio
  • The AGIR program
  • Discovery platform
  • Partners

Bioactives

  • About
  • Biodiversity
  • Portfolio
  • Platform of Expertise
  • Partners

Investor room

  • Corporate governance
  • DEINOVE Shares
  • Financial Calendar
  • Documentation Center
  • Press releases
  • Investor relations

Careers

  • Join DEINOVE
  • Open positions

News & events

  • Press releases
  • Events
  • Press coverage

Downloads

  • Investor presentations
  • Analyst Coverage
  • Financial Reports

Follow us

Stay in touch

Subscribe to our newsletter

Contact us

ZAC Euromédecine II, Cap Sigma, 1682 Rue de la Valsière, 34790 Grabels, France

+33 (0)4 48 19 01 00

Home